Finance

Lists
600085:SHA
Beijing Tong Ren Tang Co Ltd
CNÂ¥24.12
-0.04%
(-0.0100) 1D
Nov 17, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600085...
Open
CNÂ¥24.05
High
CNÂ¥24.28
Low
CNÂ¥23.96
Mkt. cap
33.09B
Avg. vol.
8.62M
Volume
6.46M
Dividend
2.07%
Quarterly dividend
CNÂ¥0.13
Ex-dividend date
Jul 1, 2026
P/E ratio
37.70
52-wk high
CNÂ¥35.56
52-wk low
CNÂ¥21.87
EPS
CNÂ¥0.64
Shares outstanding
1.37B
No. of employees
17K
Open
CNÂ¥24.05
High
CNÂ¥24.28
Low
CNÂ¥23.96
Mkt. cap
33.09B
Avg. vol.
8.62M
Volume
6.46M
Dividend
2.07%
Quarterly dividend
CNÂ¥0.13
Ex-dividend date
Jul 1, 2026
P/E ratio
37.70
52-wk high
CNÂ¥35.56
52-wk low
CNÂ¥21.87
EPS
CNÂ¥0.64
Shares outstanding
1.37B
No. of employees
17K
News stories
From web sources and news partners
Profile
Tong Ren Tang is a Chinese pharmaceutical company founded in 1669. It is now the largest producer of traditional Chinese medicine. The company headquarters are in Beijing, where they engage in both manufacturing and retail sales. It operates drug stores, predominantly in Chinese-speaking regions. Tong Ren Tang is considered one of the "Big 4" traditional Chinese medicine brands still in existence. The four companies include: Guangyuyuan, Guangzhou Chen Liji, Beijing Tong Ren Tang, and Hangzhou Hu Qing Yu Tang. Tong Ren Tang, and GuangYuYuan have been officially recognized as "China Time-Honored Brands" by the Ministry of Commerce of the People's Republic of China. Wikipedia
About Beijing Tong Ren Tang Co Ltd
CEO-
Employees17.3K
Founded1669
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
3.95B
4.66B
3.72B
2.68B
Cost of goods sold
2.50B
2.72B
2.17B
1.59B
Cost of revenue
2.50B
2.72B
2.17B
1.59B
Research and development expenses
144.52M
51.64M
74.50M
71.61M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.30B
1.13B
1.04B
842.95M
Operating expense
1.52B
1.23B
1.16B
917.04M
Total operating expenses
4.02B
3.95B
3.33B
2.51B
Operating income
-73.33M
709.73M
383.76M
173.05M
Other non operating income
-4.50M
-3.96M
-4.53M
-3.53M
EBT including unusual items
67.54M
748.37M
431.21M
165.03M
EBT excluding unusual items
-56.72M
750.60M
414.06M
233.77M
Income tax expense
27.32M
131.64M
112.60M
43.15M
Effective tax rate
40.44%
17.59%
26.11%
26.15%
Other operating expenses
58.15M
29.98M
47.32M
-295.56K
Net income
11.82M
471.18M
255.01M
139.54M
Net profit margin
0.30%
10.10%
6.86%
5.21%
Earnings per share
-
-
-
-
Interest and investment income
48.93M
70.91M
59.45M
87.32M
Interest expense
-28.19M
-26.08M
-24.57M
-23.12M
Net interest expenses
20.74M
44.83M
34.88M
64.20M
Depreciation and amortization charges
-
-
-
-
EBITDA
18.15M
801.21M
477.52M
264.53M
Gain or loss from assets sale
-25.11M
-
-10.41M
10.41M
Upcoming events
AI content may include mistakes. Learn more
Google apps